Details for New Drug Application (NDA): 076478
✉ Email this page to a colleague
NDA 076478 describes IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, which is a drug marketed by Aurobindo Pharma, Perrigo, Aurobindo Pharma Ltd, Contract Pharmacal, and Dr Reddys Labs Ltd, and is included in five NDAs. It is available from five suppliers. Additional details are available on the IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE profile page.
The generic ingredient in IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.
The generic ingredient in IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.
Summary for 076478
| Tradename: | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE |
| Applicant: | Perrigo |
| Ingredient: | ibuprofen; pseudoephedrine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML;15MG/5ML | ||||
| Approval Date: | Nov 5, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
